RECOMBIVAX HB 5 ug/.5mL

RECOMBIVAX HB 5 ug/0.5mL is a recombinant hepatitis B vaccine designed for immunization. This injection helps prevent hepatitis B infection, a serious liver disease. Suitable for various age groups, it is administered via intramuscular or subcutaneous routes.

RECOMBIVAX HB 5 ug/0.5mL is primarily used for the prevention of hepatitis B virus (HBV) infection. This vaccine is recommended for individuals at risk of exposure to HBV, including healthcare workers, travelers to regions with high HBV prevalence, and those with chronic liver disease. It is also used for routine immunization in infants, children, and adults who have not previously been vaccinated against hepatitis B. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus, providing long-term protection.

Common effects of RECOMBIVAX HB 5 ug/0.5mL may include mild soreness, redness, or swelling at the injection site. Some individuals may experience low-grade fever, headache, or fatigue following vaccination. These effects are typically mild and resolve within a few days. Severe allergic reactions are rare but can occur and require immediate medical attention.

RECOMBIVAX HB 5 ug/0.5mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current illnesses or medications before receiving the vaccine. Pregnant or breastfeeding individuals should consult their healthcare provider before vaccination.

RECOMBIVAX HB 5 ug/0.5mL may interact with certain medications or medical conditions. It is important to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, before receiving the vaccine. Alcohol consumption does not typically interact with the vaccine, but it is always best to follow the advice of a healthcare professional.